AtrophyLSS: Association Between Lumbar Muscle Atrophy, Sagittal Pelvic Alignment and Stenosis Grade in Patients With Degenerative Lumbar Spinal Stenosis

Sponsor
University Hospital, Basel, Switzerland (Other)
Overall Status
Completed
CT.gov ID
NCT04444739
Collaborator
(none)
165
1
10.9
15.1

Study Details

Study Description

Brief Summary

This study is to evaluate the correlation between muscle atrophy (MA), sagittal alignment, and stenosis degree in patients with lumbar spinal Stenosis (LSS). From existing radiological images, specific radiographic parameters will be extracted. General Information (Age, sex, levels of stenosis, duration of symptoms) will be extracted from patient files.

Condition or Disease Intervention/Treatment Phase
  • Other: radiographic data collection

Study Design

Study Type:
Observational
Actual Enrollment :
165 participants
Observational Model:
Cohort
Time Perspective:
Retrospective
Official Title:
AtrophyLSS - Association Between Lumbar Muscle Atrophy, Sagittal Pelvic Alignment and Stenosis Grade in Patients With Degenerative Lumbar Spinal Stenosis
Actual Study Start Date :
Feb 3, 2020
Actual Primary Completion Date :
Sep 30, 2020
Actual Study Completion Date :
Dec 31, 2020

Outcome Measures

Primary Outcome Measures

  1. Severity of muscle atrophy (MA) from supine Magnetic Resonance Imaging (MRI) of lumbar spine [single time-point at baseline]

    Muscle atrophy stage will be observed using Goutallier classification Stage 0: No fatty infiltration Stage 1: Few fatty streaks within the muscle Stage 2: Less than 50% fat within the muscle Stage 3: 50% of fat within the muscle Stage 4: more than 50% fat with in the muscle. The MA stage will be observed in MRI of 5 lumbar disc levels (L1-S1). The MA stage of patients will be calculated as average stage of five lumbar segments.

  2. Pelvic incidence (PI): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads [single time-point at baseline]

    Pelvic incidence (PI): The angle between the line perpendicular to the sacral endplate at its midpoint and a line connecting this point to the axis of the femoral head.

  3. Severity of stenosis from supine MRI of lumbar spine [single time-point at baseline]

    Stenosis grade will be observed using Schizas classification (Schizas et al., 2010) Grade 1: Dural sac party occupied by the rootlets; Cerebrospinal fluid clearly visible; No stenosis Grade 2: Rootlets occupy whole dural sac; Some cerebrospinal fluid visible; Moderate stenosis. Grade 3: Rootlets not visible; No cerebrospinal fluid visible; Epidural fat posteriorly; Severe stenosis. Grade 4: Rootlets not visible; No cerebrospinal fluid; No epidural fat; Extreme Stenosis. The most severe level will be regarded as the stenosis grade of the patients.

  4. Pelvic tilt (PT): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads [single time-point at baseline]

    Pelvic tilt (PT): The angle formed by a vertical line through the center of the femoral heads and the line from the center of the femoral axis and the midpoint of the sacral end plate.

  5. Sacral slope (SS): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads [single time-point at baseline]

    Sacral slope (SS): The angle formed between the horizontal and the sacral end plate.

  6. Lumbar lordosis (LL): Pelvic alignment from standard upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral heads [single time-point at baseline]

    Lumbar lordosis (LL): The sagittal angle formed between the superior end plate of L1 and the sacral end plate

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of degenerative lumbar spinal stenosis

  • Upright standing sagittal plane X-ray of lumbar spine with clear visibility of pelvis sacrum and femoral head

  • MRI of the lumbar region with clear visibility of different muscle atrophy grade

  • Consent that health related information can be used for research was signed

Exclusion Criteria:
  • Other spinal disease such as severe scoliosis, fracture, spondylolisthesis and ankylosing spondylitis.

  • Neuromuscular diseases such as M.Parkinson or multiple sclerosis

  • Previous surgery of the spine

  • Infection and/or malignancy tumor with involvement of the bony or soft tissue structures of the spine

  • Presence of a documented consent dissent.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Orthopaedics and Traumatology, University Hospital Basel Basel Switzerland 4031

Sponsors and Collaborators

  • University Hospital, Basel, Switzerland

Investigators

  • Principal Investigator: Annegret Muendermann, Prof. Dr. med., Orthopaedics and Traumatology, University Hospital Basel

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT04444739
Other Study ID Numbers:
  • 2020-00150; ch20Muendermann4
First Posted:
Jun 24, 2020
Last Update Posted:
Jun 18, 2021
Last Verified:
Jun 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by University Hospital, Basel, Switzerland
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2021